Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration

NCT03171818 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT03171818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03171818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration
Lead sponsor
UMC Utrecht
Phase
Phase 2
Overall status
Unknown status
Start date
July 1, 2017
Completion date
June 1, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal stroke, pais, perinatal stroke